Literature DB >> 17763836

Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer.

Stacey A Kenfield1, Stephanie T Chang, June M Chan.   

Abstract

Active Surveillance (AS) is a viable, alternative option for patients who are diagnosed with favorable prognostic risk prostate cancer, and who are willing to undergo conservative, expectant management until treatment is warranted due to progression of the disease. Lifestyle interventions in patients who choose AS is an emerging area of research, and several studies are ongoing with results pending. New intervention studies will increase our knowledge of the etiology of prostate cancer and help determine whether dietary factors can influence prostate carcinogenesis after diagnosis in AS patients. The considerable amount of epidemiologic and experimental data relating components of the diet with prostate cancer risk suggest that diet or lifestyle interventions could potentially lengthen the period of active surveillance before treatment management is necessary, and further research is warranted to study the direct effects on secondary clinical outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17763836     DOI: 10.1007/s11864-007-0034-0

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  63 in total

1.  Supplement use among men with prostate cancer.

Authors:  Jeremy B Wiygul; Brian R Evans; Bercedis L Peterson; Thomas J Polascik; Philip J Walther; Cary N Robertson; David M Albala; Wendy Demark-Wahnefried
Journal:  Urology       Date:  2005-07       Impact factor: 2.649

2.  A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland).

Authors:  Panagiota N Mitrou; Demetrius Albanes; Stephanie J Weinstein; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Michael F Leitzmann
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

Review 3.  An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels.

Authors:  Mark Messina; Omer Kucuk; Johanna W Lampe
Journal:  J AOAC Int       Date:  2006 Jul-Aug       Impact factor: 1.913

4.  Dietary trial in prostate cancer: Early experience and implications for clinical trial design.

Authors:  D M Ornish; K L Lee; W R Fair; E B Pettengill; P R Carroll
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

Review 5.  Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis.

Authors:  Phyllis Bowen; Longwen Chen; Maria Stacewicz-Sapuntzakis; Claudine Duncan; Roohollah Sharifi; Luna Ghosh; Hyung-Sook Kim; Konstantin Christov-Tzelkov; Richard van Breemen
Journal:  Exp Biol Med (Maywood)       Date:  2002-11

6.  Nutrient adequacy of a very low-fat vegan diet.

Authors:  Stacey R Dunn-Emke; Gerdi Weidner; Elaine B Pettengill; Ruth O Marlin; Christine Chi; Dean M Ornish
Journal:  J Am Diet Assoc       Date:  2005-09

7.  Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.

Authors:  Dong Xiao; Shivendra V Singh
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

8.  The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

Authors:  Matthew R Cooperberg; David J Pasta; Eric P Elkin; Mark S Litwin; David M Latini; Janeen Du Chane; Peter R Carroll
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

9.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

10.  The specific role of isoflavones in reducing prostate cancer risk.

Authors:  Nagi B Kumar; Alan Cantor; Kathy Allen; Diane Riccardi; Karen Besterman-Dahan; John Seigne; Mohamad Helal; Raoul Salup; Julio Pow-Sang
Journal:  Prostate       Date:  2004-05-01       Impact factor: 4.104

View more
  9 in total

Review 1.  Energetics in colorectal and prostate cancer.

Authors:  Jeffrey A Meyerhardt; Jing Ma; Kerry S Courneya
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer.

Authors:  Esther M John; Mariana C Stern; Rashmi Sinha; Jocelyn Koo
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

3.  Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.

Authors:  Joanne L Watters; Mitchell H Gail; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

4.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors:  Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

5.  Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.

Authors:  Mark Jesus M Magbanua; Ritu Roy; Eduardo V Sosa; Vivian Weinberg; Scott Federman; Michael D Mattie; Millie Hughes-Fulford; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll; June M Chan
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

6.  Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.

Authors:  Kewei Wang; Guosheng Wu; Jinping Li; Wentao Song
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

7.  Exercise duRing Active Surveillance for prostatE cancer-the ERASE trial: a study protocol of a phase II randomised controlled trial.

Authors:  Dong-Woo Kang; Adrian S Fairey; Normand G Boulé; Catherine J Field; Kerry S Courneya
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

Review 8.  What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review.

Authors:  Kim Donachie; Erik Cornel; Thomas Pelgrim; Leslie Michielsen; Bart Langenveld; Marian Adriaansen; Esther Bakker; Lilian Lechner
Journal:  Support Care Cancer       Date:  2022-01-26       Impact factor: 3.359

9.  Diversity in global gene expression and morphology across a watercress (Nasturtium officinale R. Br.) germplasm collection: first steps to breeding.

Authors:  Adrienne C Payne; Graham J J Clarkson; Steve Rothwell; Gail Taylor
Journal:  Hortic Res       Date:  2015-07-08       Impact factor: 6.793

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.